Whales with a lot of money to spend have taken a noticeably bearish stance on Moderna.
Looking at options history for Moderna MRNA we detected 11 trades.
If we consider the specifics of each trade, it is accurate to state that 18% of the investors opened trades with bullish expectations and 63% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $1,196,435 and 2, calls, for a total amount of $1,384,310.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $22.5 and $105.0 for Moderna, spanning the last three months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 3135.88 with a total volume of 4,381.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $22.5 to $105.0 over the last 30 days.
Moderna Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | CALL | TRADE | BEARISH | 02/21/25 | $5.05 | $4.8 | $4.85 | $50.00 | $1.3M | 1.5K | 2.7K |
| MRNA | PUT | TRADE | NEUTRAL | 01/16/26 | $5.5 | $4.95 | $5.25 | $30.00 | $446.2K | 1.4K | 852 |
| MRNA | PUT | SWEEP | BEARISH | 01/17/25 | $13.25 | $11.4 | $13.25 | $55.00 | $331.2K | 4.7K | 10 |
| MRNA | PUT | SWEEP | BULLISH | 03/21/25 | $12.05 | $11.85 | $11.85 | $50.00 | $141.0K | 4.0K | 120 |
| MRNA | PUT | SWEEP | BEARISH | 02/21/25 | $11.2 | $11.15 | $11.2 | $50.00 | $76.1K | 112 | 1 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Current Position of Moderna
- Currently trading with a volume of 1,119,525, the MRNA's price is up by 0.14%, now at $43.45.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 83 days.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
